Can heart failure with preserved ejection fraction (HFpEF) present with a normal left ventricular end‑diastolic pressure (LVEDP) at rest in older women with hypertension, obesity, diabetes, chronic kidney disease, or atrial fibrillation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 11, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can HFpEF Present with Normal LVEDP at Rest?

Yes, HFpEF can absolutely present with normal left ventricular end-diastolic pressure (LVEDP) at rest, particularly in earlier stages of the disease—this is a critical diagnostic pitfall that clinicians must recognize. Approximately 35% of HFpEF patients present with "unexplained" dyspnea on exertion without overt congestion or elevated filling pressures at rest, yet demonstrate markedly elevated filling pressures during exercise 1, 2.

The Exercise-Dependent Nature of Early HFpEF

Patients in earlier stages of HFpEF may only display abnormal elevation in left ventricular filling pressure during exercise, while pressures remain completely normal at rest 3. This phenomenon explains why many patients with genuine HFpEF have:

  • Normal resting LVEDP or pulmonary capillary wedge pressure (PCWP) <15 mm Hg 2
  • Normal brain natriuretic peptide levels at rest 2
  • No physical examination or radiographic signs of congestion 1

Yet during exercise hemodynamic testing, these same patients demonstrate:

  • Exercise PCWP ≥25 mm Hg (diagnostic threshold for HFpEF) 2
  • Exercise pulmonary artery systolic pressure ≥45 mm Hg (96% sensitivity, 95% specificity for HFpEF) 2
  • Blunted increases in heart rate, systemic vasodilation, and cardiac output 2

Diagnostic Implications for Your Patient Population

In older women with hypertension, obesity, diabetes, chronic kidney disease, or atrial fibrillation—the exact demographic you describe—resting hemodynamics may be entirely normal despite symptomatic HFpEF 3. The 2022 AHA/ACC/HFSA guidelines explicitly acknowledge this: "The criteria for diagnosis of HFmrEF and HFpEF require evidence of increased LV filling pressures at rest, exercise, or other provocations" 3.

When to Suspect HFpEF Despite Normal Resting Pressures

The H2FPEF score can help identify patients who need exercise testing 3:

  • Score 0-1: Low probability; pursue alternative diagnoses
  • Score 2-5: Intermediate probability; exercise echocardiography or cardiac catheterization is required to confirm or exclude HFpEF 3
  • Score ≥6: High probability (>95%) of HFpEF 3

The score incorporates: obesity, atrial fibrillation, age >60 years, ≥2 antihypertensive medications, E/e' >9, and PA systolic pressure >35 mm Hg 3.

The Biomarker Paradox in HFpEF

Normal or low-normal natriuretic peptide levels do NOT exclude HFpEF, particularly when resting filling pressures are normal 3, 4. This is because:

  • BNP/NT-proBNP reflect current hemodynamic stress rather than structural abnormalities alone 5
  • In euvolemic patients with normal resting PCWP, natriuretic peptides may be normal despite genuine diastolic dysfunction 2
  • Obesity (common in HFpEF) suppresses BNP levels by 20-30%, potentially masking cardiac dysfunction 4, 5
  • Approximately 29% of symptomatic HFpEF patients with elevated exercise PCWP have BNP ≤100 pg/mL 4

The 2009 ACC/AHA guidelines explicitly state: "A normal BNP level along with completely normal diastolic end-filling parameters makes HF much less likely; however, HF does remain a strictly clinical diagnosis" 3.

Recommended Diagnostic Approach

When HFpEF is suspected but resting hemodynamics are normal:

  1. Calculate the H2FPEF score using clinical and resting echocardiographic data 3

  2. If score 2-5 (intermediate probability), proceed to:

    • Exercise stress echocardiography with Doppler assessment of E/e' and estimated PA pressures 3, 6
    • OR invasive exercise hemodynamics measuring PCWP, PA pressures, stroke volume, and cardiac output during supine bicycle exercise 3, 2
  3. Diagnostic thresholds during exercise:

    • Exercise PCWP ≥25 mm Hg confirms HFpEF 2
    • Exercise PA systolic pressure ≥45 mm Hg has 96% sensitivity and 95% specificity 2

Critical Clinical Pitfalls to Avoid

  • Do not rely solely on resting hemodynamics to exclude HFpEF in patients with unexplained exertional dyspnea and typical risk factors 3, 2
  • Do not dismiss the diagnosis based on normal BNP/NT-proBNP alone, especially in obese patients 4, 5
  • Do not assume normal resting E/e' excludes HFpEF—diastolic parameters are readily altered by transient changes in loading conditions 3
  • Recognize that earlier-stage HFpEF is fundamentally an exercise-induced hemodynamic disorder that may be completely masked at rest 3, 2

The key insight is that HFpEF exists on a spectrum: advanced disease presents with overt resting congestion and elevated filling pressures, while earlier disease manifests only during physiologic stress 1, 2. In your patient population (older women with metabolic comorbidities), a high index of suspicion and low threshold for exercise testing is warranted when exertional symptoms cannot be explained by alternative diagnoses 3, 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Role of NT-proBNP in Diagnosing and Managing Heart Failure

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

BNP as an Indicator of Heart Failure Severity

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Echocardiographic Diagnosis of Heart Failure with Preserved Ejection Fraction

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What are the best management options for an elderly female patient with a history of heart failure with preserved ejection fraction (HFpEF), complete heart block/atrial fibrillation with a pacemaker, coronary artery disease (CAD), chronic kidney disease stage 3a (CKD 3a), uremia, hypertension (HTN), hyperlipidemia, pulmonary hypertension (Pulm HTN), bilateral lower extremity edema due to severe peripheral arterial disease (PAD), gastroesophageal reflux disease (GERD) with hiatal hernia, and failure to thrive, who is a Do Not Resuscitate (DNR) and has been refusing to eat and has hypothermia after removal of her nasogastric (NG) tube?
What alternative medication might be considered for a 61-year-old male with seizure disorders, currently taking lamotrigine (Lamotrigine) and eslicarbazepine (Aptiom), to reduce the risk of serious arrhythmias given his history of heart failure with preserved ejection fraction (HFpEF)?
What is the best course of treatment for a 72-year-old female (F) patient with sudden onset dyspnea, elevated N-terminal pro b-type natriuretic peptide (NT Pro BNP), concentric left ventricular hypertrophy (LVH) with preserved contractility on 2-dimensional echocardiogram (2D echo), hypertension, and no history of diabetes or chronic kidney disease (CKD)?
What alternative medication might be considered for a 61-year-old male with seizure disorders, currently taking abdominal (abdominal) matrix, likely referring to (Anti-Epileptic Drug), to reduce the risk of serious arrhythmias given his history of Heart Failure with Preserved Ejection Fraction (HFpEF)?
What is the best management plan for a 57-year-old female with a past medical history of Heart Failure with preserved Ejection Fraction (HFpEF), paroxysmal Atrial Fibrillation (A-fib) on warfarin (Coumadin), poorly controlled Type 2 Diabetes Mellitus (DM 2), Hypertension (HTN), Hyperlipidemia (HLD), and Chronic Obstructive Pulmonary Disease (COPD), presenting with increased edema, weight gain, and shortness of breath?
How should I manage persistent hyperphosphatemia in a peritoneal dialysis patient?
Is complicated cystitis the same as complicated pyelonephritis?
How does tricuspid regurgitation affect central venous pressure?
Can azithromycin be prescribed for a 5‑month‑old infant?
In a patient with neuropathy and a normal glycated hemoglobin (HbA1c), what further evaluation and management should be undertaken?
What is tumor lysis syndrome, including its risk factors, pathophysiology, diagnostic criteria, prevention, and management?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.